ARENSIA Trademark

Trademark Overview

On Friday, May 18, 2012, a trademark application was filed for ARENSIA with the United States Patent and Trademark Office. The USPTO has given the ARENSIA trademark a serial number of 79114553. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, May 8, 2024. This trademark is owned by ARENSIA Exploratory Medicine GmbH. The ARENSIA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical trials for others; clinical and medical research, namely, providing scientific research in the field of clinical trials, conducting clinical research in the field of respiratory science, conducting pharmaceutical clinical trials for others; [ scientific services and research and scientific experiments, namely, developing programs for simulating experiments or series of experiments in a virtual optical laboratory, scientific laboratory services, ] scientific research services for others in the fields of cardiology, immunology, metabolic disorders, respiratory, endocrinology, gastro-enterology, hepatology, nephrology, dermatology, urology, oncology, psychiatry, neurology; scientific reports, namely, providing scientific information in the fields of cardiology, immunology, metabolic disorders, respiratory, endocrinology, gastro-enterology, hepatology, nephrology, dermatology, urology, oncology, psychiatry, neurology; providing research and development in the fields of cardiology,...
arensia

General Information

Serial Number79114553
Word MarkARENSIA
Filing DateFriday, May 18, 2012
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, May 8, 2024
Registration Number4460438
Registration DateTuesday, January 7, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2013

Trademark Statements

Goods and ServicesClinical trials for others; clinical and medical research, namely, providing scientific research in the field of clinical trials, conducting clinical research in the field of respiratory science, conducting pharmaceutical clinical trials for others; [ scientific services and research and scientific experiments, namely, developing programs for simulating experiments or series of experiments in a virtual optical laboratory, scientific laboratory services, ] scientific research services for others in the fields of cardiology, immunology, metabolic disorders, respiratory, endocrinology, gastro-enterology, hepatology, nephrology, dermatology, urology, oncology, psychiatry, neurology; scientific reports, namely, providing scientific information in the fields of cardiology, immunology, metabolic disorders, respiratory, endocrinology, gastro-enterology, hepatology, nephrology, dermatology, urology, oncology, psychiatry, neurology; providing research and development in the fields of cardiology, immunology, metabolic disorders, respiratory, endocrinology, gastro-enterology, Hepatology, nephrology, dermatology, urology, oncology, psychiatry, neurology; research on the subject of pharmaceuticals; consultancy in relation to scientific research; scientific consultancy services, namely, scientific research consulting in the fieldsof cardiology, immunology, metabolic disorders, respiratory, endocrinology, gastro-enterology, hepatology, nephrology, dermatology, urology, oncology, psychiatry, neurology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 23, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameARENSIA Exploratory Medicine GmbH
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressDE
Party NameARENSIA Exploratory Medicine GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDüsseldorf 40225
DE
Party NameARENSIA Exploratory Medicine GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameARENSIA Exploratory Medicine GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Monday, September 10, 2012ASSIGNED TO EXAMINER
Thursday, July 19, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 23, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 27, 2012APPLICATION FILING RECEIPT MAILED
Tuesday, September 11, 2012NON-FINAL ACTION WRITTEN
Wednesday, September 12, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 12, 2012REFUSAL PROCESSED BY MPU
Wednesday, September 12, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, September 30, 2012REFUSAL PROCESSED BY IB
Sunday, March 10, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 10, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, March 10, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 10, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 14, 2013FINAL REFUSAL WRITTEN
Thursday, March 14, 2013FINAL REFUSAL E-MAILED
Thursday, March 14, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 12, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, September 12, 2013EXAMINERS AMENDMENT E-MAILED
Thursday, September 12, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 12, 2013ASSIGNED TO LIE
Thursday, September 12, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, September 12, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 16, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 2, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 2, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 2, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, October 20, 2013NOTIFICATION PROCESSED BY IB
Tuesday, October 22, 2013PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 18, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, November 30, 2013NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 7, 2014REGISTERED-PRINCIPAL REGISTER
Monday, April 7, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, May 22, 2014FINAL DISPOSITION PROCESSED
Thursday, May 22, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 6, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 7, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, December 17, 2019TEAS SECTION 71 & 15 RECEIVED
Wednesday, February 5, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 5, 2020REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Wednesday, February 5, 2020NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Friday, February 11, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, June 2, 2022INTERNATIONAL REGISTRATION RENEWED
Monday, July 11, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 11, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, January 7, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, September 6, 2023TEAS SECTION 71 RECEIVED
Wednesday, May 8, 2024REGISTERED-SEC.71 ACCEPTED
Wednesday, May 8, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, May 6, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 9, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 21, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, March 21, 2025INVALIDATION PROCESSED
Saturday, April 12, 2025PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, July 4, 2025CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

arensia scientific research clinical fields cardiology services respiratory providing trials experiments